Effects of insulin detemir and NPH insulin on renal handling of sodium, fluid retention and weight in type 2 diabetic patients

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

Effects of insulin detemir and NPH insulin on renal handling of sodium, fluid retention and weight in type 2 diabetic patients. / Hendriksen, K V; Jensen, Tonny Joran; Oturai, P; Feldt-Rasmussen, B.

I: Diabetologia, Bind 55, Nr. 1, 2012, s. 46-50.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Hendriksen, KV, Jensen, TJ, Oturai, P & Feldt-Rasmussen, B 2012, 'Effects of insulin detemir and NPH insulin on renal handling of sodium, fluid retention and weight in type 2 diabetic patients', Diabetologia, bind 55, nr. 1, s. 46-50. https://doi.org/10.1007/s00125-011-2345-8

APA

Hendriksen, K. V., Jensen, T. J., Oturai, P., & Feldt-Rasmussen, B. (2012). Effects of insulin detemir and NPH insulin on renal handling of sodium, fluid retention and weight in type 2 diabetic patients. Diabetologia, 55(1), 46-50. https://doi.org/10.1007/s00125-011-2345-8

Vancouver

Hendriksen KV, Jensen TJ, Oturai P, Feldt-Rasmussen B. Effects of insulin detemir and NPH insulin on renal handling of sodium, fluid retention and weight in type 2 diabetic patients. Diabetologia. 2012;55(1):46-50. https://doi.org/10.1007/s00125-011-2345-8

Author

Hendriksen, K V ; Jensen, Tonny Joran ; Oturai, P ; Feldt-Rasmussen, B. / Effects of insulin detemir and NPH insulin on renal handling of sodium, fluid retention and weight in type 2 diabetic patients. I: Diabetologia. 2012 ; Bind 55, Nr. 1. s. 46-50.

Bibtex

@article{1d61ef9e7dce4a6d972844af1240a700,
title = "Effects of insulin detemir and NPH insulin on renal handling of sodium, fluid retention and weight in type 2 diabetic patients",
abstract = "In type 2 diabetic patients, insulin detemir (B29Lys(ε-tetradecanoyl),desB30 human insulin) induces less weight gain than NPH insulin. Due to the proposed reduction of tubular action by insulin detemir, type 2 diabetic patients should have increased urinary sodium excretion, thereby reducing extracellular volume and body weight when changed from NPH insulin to insulin detemir.",
author = "Hendriksen, {K V} and Jensen, {Tonny Joran} and P Oturai and B Feldt-Rasmussen",
year = "2012",
doi = "10.1007/s00125-011-2345-8",
language = "English",
volume = "55",
pages = "46--50",
journal = "Diabetologia",
issn = "0012-186X",
publisher = "Springer",
number = "1",

}

RIS

TY - JOUR

T1 - Effects of insulin detemir and NPH insulin on renal handling of sodium, fluid retention and weight in type 2 diabetic patients

AU - Hendriksen, K V

AU - Jensen, Tonny Joran

AU - Oturai, P

AU - Feldt-Rasmussen, B

PY - 2012

Y1 - 2012

N2 - In type 2 diabetic patients, insulin detemir (B29Lys(ε-tetradecanoyl),desB30 human insulin) induces less weight gain than NPH insulin. Due to the proposed reduction of tubular action by insulin detemir, type 2 diabetic patients should have increased urinary sodium excretion, thereby reducing extracellular volume and body weight when changed from NPH insulin to insulin detemir.

AB - In type 2 diabetic patients, insulin detemir (B29Lys(ε-tetradecanoyl),desB30 human insulin) induces less weight gain than NPH insulin. Due to the proposed reduction of tubular action by insulin detemir, type 2 diabetic patients should have increased urinary sodium excretion, thereby reducing extracellular volume and body weight when changed from NPH insulin to insulin detemir.

U2 - 10.1007/s00125-011-2345-8

DO - 10.1007/s00125-011-2345-8

M3 - Journal article

C2 - 22002075

VL - 55

SP - 46

EP - 50

JO - Diabetologia

JF - Diabetologia

SN - 0012-186X

IS - 1

ER -

ID: 48445263